Walleye Capital’s Medifast MED Stock Holding History

Walleye Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$569K	Buy	+55,800	New	+$602K	﹤0.01%	2561
2025 Q4	–	Sell	-26,100	Closed	-$357K	–	4904
2025 Q3	$357K	Buy	26,100 +26,000	+26,000%	+$363K	﹤0.01%	2872
2025 Q2	$1.41K	Sell	100 -4,900	-98%	-$64.4K	﹤0.01%	4397
2025 Q1	$67.4K	Buy	+5,000	New	+$75.1K	﹤0.01%	3766
2024 Q4	–	Sell	-300	Closed	-$5.74K	–	5258
2024 Q3	$5.74K	Sell	300 -4,300	-93%	-$82.9K	﹤0.01%	4985
2024 Q2	$100K	Sell	4,600 -9,500	-67%	-$253K	﹤0.01%	4712
2024 Q1	$540K	Buy	+14,100	New	+$683K	﹤0.01%	3126
2023 Q4	–	Sell	-7,900	Closed	-$591K	–	5286
2023 Q3	$591K	Buy	7,900 +5,500	+229%	+$488K	﹤0.01%	2681
2023 Q2	$221K	Buy	2,400 +2,100	+700%	+$187K	﹤0.01%	3016
2023 Q1	$31.1K	Sell	300 -600	-67%	-$66.5K	﹤0.01%	3302
2022 Q4	$104K	Buy	+900	New	+$105K	﹤0.01%	2347
2019 Q3	–	Sell	-5,600	Closed	-$718K	–	2107
2019 Q2	$718K	Sell	5,600 -1,900	-25%	-$264K	0.08%	363
2019 Q1	$957K	Buy	+7,500	New	+$951K	0.16%	180

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Walleye Capital's MED Position: Q1 2026 in Review

Walleye Capital opened a new position in Medifast (MED) in Q1 2026: 1 share worth $10. The stake represents ﹤0.01% of the portfolio and ranks #4312 among its holdings. This is a return to the name: Walleye Capital previously reported a position in MED as recently as Q3 2025.

Walleye Capital first reported a position in MED in Q2 2019 and has held it in 14 quarters since. The position peaked at $2.2M in Q3 2022. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

Walleye Capital held 1 share of Medifast worth $10 as of Q1 2026.
Medifast was a new Walleye Capital position in Q1 2026.
Medifast made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4312 holding.
Walleye Capital first reported a position in Medifast in Q2 2019 and has held it in 14 quarters since.
Walleye Capital's Medifast position peaked at $2.2M in Q3 2022.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.